Inflammopharmacology is the official publication of the Gastrointestinal Section of the International Union of Basic and Clinical Pharmacology (IUPHAR) and the Hungarian Experimental and Clinical Pharmacology Society (HECPS). Inflammopharmacology publishes papers on all aspects of inflammation and its pharmacological control emphasizing comparisons of (a) different inflammatory states, and (b) the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions. The comparative aspects of the types of inflammatory conditions include gastrointestinal disease (e.g. ulcerative colitis, Crohn's disease), parasitic diseases, toxicological manifestations of the effects of drugs and environmental agents, arthritic conditions, and inflammatory effects of injury or aging on skeletal muscle. The journal has seven main interest areas:
-Drug-Disease Interactions - Conditional Pharmacology - i.e. where the condition (disease or stress state) influences the therapeutic response and side (adverse) effects from anti-inflammatory drugs. Mechanisms of drug-disease and drug disease interactions and the role of different stress states
-Rheumatology - particular emphasis on methods of measurement of clinical response effects of new agents, adverse effects from anti-rheumatic drugs
-Gastroenterology - with particular emphasis on animal and human models, mechanisms of mucosal inflammation and ulceration and effects of novel and established anti-ulcer, anti-inflammatory agents, or antiparasitic agents
-Neuro-Inflammation and Pain - model systems, pharmacology of new analgesic agents and mechanisms of neuro-inflammation and pain
-Novel drugs, natural products and nutraceuticals - and their effects on inflammatory processes, especially where there are indications of novel modes action compared with conventional drugs e.g. NSAIDs
-Muscle-immune interactions during inflammation [...]
《INFLAMMOPHARMACOLOGY》期刊已被查看: 次
此期刊被最新的JCR期刊SCIE收录
期刊官网:https://www.springer.com/10787 |
---|
期刊投稿网址:https://www.editorialmanager.com/iphm |
PubMed Central (PMC)链接 :http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0925-4692%5BISSN%5D |
通讯地:PICASSOPLATZ 4, BASEL, SWITZERLAND, 4052 |
中国科学院《国际期刊预警名单(试行)》名单 |
2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 此期刊被最新的JCR期刊SCIE收录 |
版面费 | 审稿速度 | 收录数据库 | 是否oa | 研究方向 |
---|---|---|---|---|
SCIE,Scopus | No | IMMUNOLOGYTOXICOLOGY-TOXICOLOGY |
大类学科 | 分区 | 小类学科 | Top期刊 | 综述期刊 |
---|---|---|---|---|
医学 | 2区 | TOXICOLOGY 毒理学 IMMUNOLOGY 免疫学 |
否 | 否 |
版本 | 按学科 | 分区 | 影响因子 |
---|---|---|---|
2023-2024年最新版 | IMMUNOLOGY TOXICOLOGY |
Q1 | 4.6 |
Journal of Inclusive Postsecondary EducationJCR:0区,分类:影响因子0收录DOAJ
详情StichprobenJCR:0区,分类:影响因子0收录DOAJ
详情EManagementJCR:0区,分类:影响因子0收录DOAJ
详情Metathesis Journal of English Language Literature and TeachingJCR:0区,分类:影响因子0收录DOAJ
详情Clinical Psychology in EuropeJCR:0区,分类:影响因子0收录Scopus,DOAJ
详情Ius InkarriJCR:0区,分类:影响因子0收录DOAJ
详情Medichna nauka UkrayiniJCR:0区,分类:影响因子0收录DOAJ
详情Economics LawJCR:0区,分类:影响因子0收录DOAJ
详情